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Reversed-phase high performance liquid chromatographic (RP-
HPLC) determination of amino-acids with on-line pre-column
ortho-phthalaldehyde (OPA) derivatization and fluorescence
detection is rapid and sensitive. However, high-performance ion-
exchange chromatography (HP-IEC) withpost-column ninhydrine
reaction is the most widely used amino-acid (AA) assay for
biological samPles. These two methods have been comparedfor the
determination of individual plasma AA concentrations.
An excellent correlation (p < 0"003) wasfound between the results
given by an RP-HPLC system (Varian) and a classicalAA auto-
analyser (Biotronik LC 5001). Most AA concentrations were
similar with the two methods, but a paired t-test showed slight
differencesfor 13AA. The within-batch reproducibility ofthe RP-
HPLC method was comparable to that of the HP-IEC method.
The analysis was about three times faster with RP-HPLC, and
sensitivity was lO0-fold better. However, aspartic acid, proline and
cysteine were not identified by the RP-HPLC method, while the
tryptophan quantification is possible.
RP-HPLC-based assays involve pre-column deriva-
tization with various agents such as ortho-phthalalde-
hyde (OPA) [7], phenylisothiocyanate (PITC) [8], 9-
fluorenylmethylchloroformate (FMOC) [9], and 4-
fluoro-7-nitrobenzo-2-oxa-l,3-diazole (NBD-F) [10].
There is a general preference for OPA, given its simplicity
of use, but, paradoxically, the speed of elution makes it
difficult to separate the numerous AAs present in plasma.
Several solutions to this problem have been proposed
[11-13] differing by the nature ofthe buffers, the length of
the column and/or the size of the solid-phase particles.
Another major problem with OPA derivatives is their
instability, which means that the time between derivative
formation and injection into the HPLC system must be
carefully controlled [14]. An apparatus in which the
mixing and sampling steps are automated should thus be
suitable for routine (24-hour) OPA-based plasma AA
analysis.
The performance of an OPA-based method derived from
that of Fiirst et al. 15] using the automatic Vista Varian
system was evaluated and the results compared to those
given by automated HP-IEC.
RP-HPLC with automated pre-column OPA derivatization is
clearly a suitable alternative for assaying physiological AA and
may be particularly useful for AA present at low concentrations
(free tr_yptophan, plasma 3-methylhistidine).
Introduction
The most widely used method for amino-acid (AA)
determination in biological fluids is high-performance
ion-exchange chromatography (HP-IEC) [1,2]. How-
ever, despite considerable improvements [3-5], the run
time is still lengthy and when ninhydrin-based detection
is used, the method is poorly sensitive for AAs present at
low concentrations, such as aspartic acid, citrulline,
methionine and tryptophan [6].
Reversed-phase high-performance liquid chroma-
tography (RP-HPLC) is an alternative method. Most
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Materials and methods
RP-HPLC method
Apparatus
The Varian RP2HPLC system (Walnut Creek, USA)
consists of a model-9090 autosampler coupled to a Vista
5500 liquid chromatograph, a model-2070 spectrofluori-
metric detector (excitation wavelength 330 nm, emission
wavelength 450 nm) and a model-4290 integrator. The
chromatographic column was a Spherisorb ODS II [15
cm x 4"6 mm (ID)] packed with 3-tm particles and
equipped with a 10 mm x 4"6 mm (ID) guard column
(Socifitfi Franaise de Chromato Colonne, Neuilly-Plai-
sance, France).
Two buffers (A and B) were prepared using ultrapure
water generated with a Milli-Q system (Millipore,
Molsheim, France). The chemicals were of analytical
grade and the solvents of chromatographic grade. Buffer
A contained 12"5 mM sodium phosphate and 0"5%
tetrahydrofuran (THF, Merck) and was adjusted to pH
0142-0453/92 $3.00 () 1992 Taylor & Francis Ltd.
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7"2. Buffer B consisted of 12"5 mM sodium phosphate,
methanol (Farmitalia Carlo Erba, Milano, Italia) and
acetonitrile (Merck, Darmstadt, Germany), (50/35/15 by
volume), adjusted to pH 7"2.
The buffers were filtered through 0"22 btm filters (Milli-
pore) and directly delivered into the HPLC reservoirs
(Ultraware System, Bioblock, Illkirch, France).
Standard and sample preparation
A 200 btM stock standard solution containing 28 physiolo-
gical AAs was prepared using a commercial solution
(AA-S-18, Sigma, La Verpillire, France); 0-aminobu-
tyric acid, asparagine, carnosine, citrulline, glutamine, 1-
methylhistidine, 3-methylhistidine, ornithine, taurine
and tryptophan (Sigma) were also added. Before analy-
sis, the standard and samples were diluted (1/20) in
buffer A containing norvaline (Sigma) as internal
standard.
OPA-3MPA reagent preparation
50 mg of OPA (Sigma) were dissolved in 100 ml of
potassium borate buffer (1"0 M, pH 10"4) (Varian). 100
btl of 3-mercaptopropionic acid (3MPA) was then added
and the solution was filtered through a 0"22 btm filter
(Millipore). The solution is stable for up to two days
when kept in the dark at 4C under nitrogen.
Autosampling process
The autosampler automatically mixes the reagents,
washes the tubing, and injects the mixtures into the
analytical column; an autostart signal is transmitted to
the pump and integrator programs.
The OPA-3MPA reagent, the samples and the diluting
buffer (buffer A) were placed separately in different
brown self-sealing microvials on the autosampler racks.
10 tl of OPA reagent are aspirated from the vial, and
ejected into an empty self-sealing microvial; the tubing is
then washed three times with buffer A, and 10 tl of the
sample is added. After a further wash, 80 tl volume of
buffer A are added. After mixing by three flux/reflux
steps, 30 ptl are aspirated through the 20 tl sample loop in
the injection valve and injected into the analytical
column. The tubing is washed nine times to prevent
cross-contamination between the samples and reagents.
The autosampling process starts 12 min before injection,
while the pump program is still running. The OPA
reagent and sample are in contact for precisely 3 min
prior to the injection.
Elution program and chromatographic conditions
With a constant flow rate of0"9 ml/min, theAA are eluted
by linearly increasing the percentage ofbuffer B from 0 to
100% over 43 min. Buffer B is maintained at 100% for 2
min and then reduced to 0% in 2 min. The column is
equilibrated with 100% bufferA for 8 min before the next
sample injection (total run time 55 min).
At the flow rate used, the basal pressure is about 150 bars;
during the analysis, it increases to about 250 bars
in parallel with the increase in the viscosity of the mobile
phase due to mixing of the buffers. Pressure returns to
base-line after equilibration of the column.
HP-IEC method
The HP-IEC system used in this study consisted of a
conventional integrated AA autoanalyser (Biotronik LC
5001, Munich, Germany) with postcolumn reaction with
ninhydrine [16], and detection at both 440 and 570 nm.
The data were collected using an SP 4290 integrator
(Spectra Physics, San Jose, USA).
Subjects
Blood was drawn into heparinized tubes after an
overnight fast from a forearm vein of 27 healthy subjects
(age: 28 + 5 years 15M, 12F). Plasma was immediately
separated by centrifugation (4C), deproteinized with
sulphosalicylic acid (SSA; 50 mg. ml-’) and stored at
-20C until analysis.
Statistical analysis
X
2 and Kolmogorov-Smirnov tests showed that plasma
AA concentrations were normally distributed, in agree-
ment with the literature [17]; Student’s paired and
unpaired t-tests were thus applied, using the PCSM
Deltasoft program package (Grenoble, France).
Results are given as mean + standard deviation (x +
SD).
Results and discussion
In the conditions described above, the RP-HPLC method
separated 24 AAs (including norvaline, the internal
standard). Typical chromatograms for the standard and
plasma AAs are shown in figure 1. The last OPA-3MPA
derivative (lysine) was eluted in less than 40 min. The
analysis of a single sample took 55 min with RP-HPLC
and 141 min with HP-IEC.
The results of the analysis of plasma samples from 27
healthy volunteers by means of the two methods are
summarized in table 1. The values were slightly different
for 13 AA (paired t-test < 0"05), but remained within the
same range. Correlations between the results of the two
methods are also shown in table 1. A very strong
correlation was obtained for all the AAs analysed, with
the exception of MET; as the plasma concentration of
MET was the lowest of the AAs studied, the IEC method
may have given an erroneous value as it is less sensitive
than the OPA-3MPA method.
The repeatability ofthe assays was studied by performing
ten consecutive measurements. The coefficient of varia-
tion (CV) for the RP-HPLC method ranged from 2" 1%
(ILE) to 5"7% (LYS), values similar to those ofHP-IEC
(from 1"9% [GLN] to 3"5% [HIS]). The CVs for RP-
HPLC were much lower than those obtained recently by
Fermo et al. [18], who used 2-mercaptoethanol rather
than 3MPA, but it is known that this reagent forms less
stable derivatives [12].
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Figure 1. Typical chromatograms ofan (automated) OPA-3MPA derivatized (A) amino-acid standard and (B) human plasma. SSA
sulfosalicylic acid (deproteinizing agent), ASP aspartic acid, GLU glutamic acid, ASN asparagine, SER serine, GLN
glutarnine, GLY glycine, THR threonine, HIS histidine, CIT citrulline, 1MH 1-methylhistidine,3MH 3-rnethylhistidine,
ALA alanine, TAU taurine, ARG arginine, CAR carnosine, AAB o-aminobutyric acid, TYR tyrosine, VAL valine,
MET methionine, NORVAL norvaline (internal standard), TRP tryptophan, PHE phenylalanine, ILE isoleucine, LEU
leucine, ORN ornithine, LYS lysine.
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Table 1. Correlations between RP-HPLC and HP-IEC results
for plasma AA concentrations in healthy subjects.
Amino-acid
(AA)
RP-HPLC HP-IEC Coefficient of
x + SD x +_ SD correlation*
(tmol/1) (tmol/1) between the
(N 27) (N 27) two methods
GLU 86 + 74 67 + 44 0.81
ASN 46 +_ 7 65 + 10 0.90
SER 118 + 15 119 + 20 0.89
GLN 493 + 95 554 + 113 0.95
GLY 221 + 41 216 + 47 0.9.5
THR 121 + 22 140 _+ 27 0.95
HIS 109_+ 14 91 + 11 0.66
CIT 24 + 5 33 + 7 0.60
ALA 340 + 50 358 + 56 0.70
TAU 70 + 11 75 + 11 0.80
ARG 82 + 20 81 + 21 0.93
AAB 22 + 6 28 +_ 6 0.87
TYR 57_+ 13 55_+ 12 0.93
VAL 232 + 40 255 + 36 0.96
MET 31 _+ 5 21 + 4 0.55
TRP 38 + 5
PHE 54 + 7 76 + 9 0.75
ILE 65 + 12 63 +_ 13 0.96
LEU 124 + 21 123 + 21 0.95
ORN 50 + 10 65 + 17 0.75
LYS 150 + 27 211 + 28 0.88
p < 0.05 versus HP-IEC (paired t-test).
* p < 0"001 for all AAs except MET, p < 0"003.
before sampling reduces OPA-induced interference,
resulting in a stable base-line.
The OPA-based RP-HPLC method does, however, have
some of the disadvantages of other OPA methods,
particularly the fact that imino-acids such as proline and
hydroxyproline cannot be derived directly [3,4]. The
cysteine derivative shows a low fluorescence intensity,
but this can be overcome by, for example, pretreating the
sample with iodoacetic acid 19]. ASP coelutes with SSA
but this problem can be by-passed by using acetonitrile as
the deproteinizing agent [20].
Finally, in the analytical conditions used here, 3-
methylhistidine (3MH) coeluted with 1-methylhistidine
(1MH). Plasma 3MH, a marker of myofibrillar catabo-
lism assessed by measuring arterio-venous differences
[21 ], can be measured specifically by simply changing the
composition of buffer B [22], and adapting the elution
program (not shown).
In conclusion, RP-HPLC with fluorescence detection of
OPA-3MPA derivatives is a rapid and reliable method
for the quantitative determination of free AAs in human
plasma. Its greater sensitivity (100-fold) than HP-IEC
with ninhydrine detection should make it applicable to
measurements of AAs present at low concentrations in
plasma (for example free TRP or 3MH).
In comparison with HP-IEC, the OPA-3MPA method
has the major advantage of having widespread appli-
cations because of its analytical versatility; in addition, it
requires only two buffers rather than five.
The OPA derivatization method is simpler than other
RP-HPLC methods since the derivatives are performed
in aqueous conditions, and evaporation and heating steps
are not required.
Tryptophan (TRP) was well separated and the fluores-
cence response of its derivative was comparable to that of
aliphatic AA. TRP is more difficult to measure with HP-
IEC because of its low sensitivity to ninhydrine and its
relatively low plasma concentration (less than 50 mol/1).
RP-HPLC separation with OPA-3MPA pre-deriva-
tization is thus useful for determining this essential AA.
Good overall analytical precision was obtained despite
differences in derivative stability. The major reason is
probably the reduced time between derivatization and
injection that automation allows. Secondly, as stated
above, the use of 3MPA instead of 2 mercaptoethanol,
improves derivative stability [12]. Interactions between
OPA-3MPA derivatives and the reversed-phase column
result in a better peak resolution and stable retention
times. Resolution was also improved by including
tetrahydrofuran and methanol in buffers A and B,
respectively. Base-line pressure is reduced and separation
is preserved by shortening the column (15 cm instead of
25 cm) 12,15]. The additional automated dilution / 10)
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